Drug intelligence / Profile preview

Xiaoyue Pill

Development stage
Unknown
Lead developer
Changchun Leiyunshang Pharmaceutical
Administration
Oral
01

Overview

Xiaoyue Pill (also known as Xiaoying Wan) is a traditional Chinese medicine (TCM) oral herbal formulation developed and manufactured by Changchun Leiyunshang Pharmaceutical. It is an approved therapeutic in China, primarily indicated for the treatment of goiter (thyroid enlargement) and thyroid nodules. The formula is based on traditional principles of 'softening hardness and dissipating nodules,' a therapeutic approach used in TCM to address glandular swellings and masses in the neck area. The preparation typically contains a complex mixture of herbal ingredients, including iodine-rich seaweeds such as Sargassum (Haizao) and Laminaria (Kunbu), along with other components like Fritillaria (Beimu) that are traditionally used to resolve phlegm and reduce swellings. As a multi-herb TCM product, its clinical effect is attributed to the synergistic action of various phytochemicals rather than a single molecular target.

Brand names
Xiaoyue Pill
Other names
Xiaoying WanXiaoying Pill消瘿丸

Beyond the preview

Go deeper on Xiaoyue Pill.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiaoyue Pill.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call